ATrx2

ATrx2 (PF3D7_0529100) is a thioredoxin-like component of the Plasmodium Translocon of Exported Proteins (PTEX), the machinery that mediates protein export across multiple life-cycle stages (PMID:23869529). Unlike other PTEX core subunits, ATrx2 can be deleted; in P. berghei, knockout parasites remain viable but exhibit reduced growth in vivo and in vitro and reduced capacity to cause severe disease in a cerebral malaria model, indicating that ATrx2 is not essential but optimizes PTEX activity (PMID:23869529). Consistent with export occurring throughout the parasite life cycle, tagged ATrx2 is detected in asexual blood stages, early gametocytes, mosquito stages, and liver stages (PMID:23869529). Biochemically, ATrx2 is a poor substrate for thioredoxin reductase and lacks access to it in its subcellular compartment, but it can be reduced by the glutathione/glutaredoxin pathway, positioning it at a point of cross-talk between the parasite's glutathione and thioredoxin antioxidant systems (PMID:28479253). Beyond these findings, the redox role of ATrx2 within PTEX and its physiological substrates have not been characterized in the available corpus.

1. 2013 High

   Establishing whether ATrx2 is a bona fide PTEX subunit and whether it is required for parasite survival was needed to define its role in protein export; genetic tagging placed it in the complex and knockout revealed it is dispensable but growth- and virulence-promoting.

   Evidence Genetic tagging and co-purification plus knockout with in vivo/in vitro growth assays and a cerebral malaria model

   PMID:23869529

   Open questions at the time

   • The molecular contribution of ATrx2 to translocation (e.g. a redox step) was not defined
   • The reduced-growth phenotype was shown in P. berghei; equivalent knockout phenotype in P. falciparum was not established
   • No substrates or interaction interface within PTEX mapped
2. 2013 Medium

   Whether ATrx2-dependent export operates outside asexual blood stages was open; detection of tagged ATrx2 across gametocyte, mosquito, and liver stages indicated PTEX-associated activity spans the life cycle.

   Evidence Expression analysis of tagged PTEX components across life-cycle stages

   PMID:23869529

   Open questions at the time

   • Expression detection does not establish functional export requirement at each stage
   • Single-study, single-lab detection without independent confirmation
3. 2017 Medium

   How ATrx2, a thioredoxin-like protein, is kept in a reduced state was unknown; in vitro assays showed it is a poor thioredoxin reductase substrate but is reducible by the glutathione system, revealing cross-talk between the two antioxidant networks.

   Evidence In vitro biochemical reduction assays measuring cross-system reduction by glutathione pathway components

   PMID:28479253

   Open questions at the time

   • In vitro assay from a single lab without mutagenesis or structural validation
   • The physiological redox substrates of ATrx2 and the link to PTEX function were not established
   • Subcellular compartment claim inferred from access data rather than direct localization

• It remains unknown what redox reaction, if any, ATrx2 performs during protein translocation and which exported substrates or PTEX partners depend on its thioredoxin-like activity.
• No mechanistic link between ATrx2 redox activity and PTEX translocation demonstrated
• No structural model of ATrx2 or its complex interface
• No identified physiological reducing substrates